KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of EFTR
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Thursday for eFFECTOR Therapeutics, Inc. stock after losing 2.16%
(Updated on Apr 25, 2024)

Sell candidate since Apr 04, 2024 Loss -38.85% PDF

The eFFECTOR Therapeutics, Inc. stock price fell by -2.16% on the last day (Thursday, 25th Apr 2024) from $1.85 to $1.81. During the last trading day the stock fluctuated 6.25% from a day low at $1.76 to a day high of $1.87. The price has fallen in 7 of the last 10 days and is down by -19.02% for this period. Volume has increased on the last day by 70 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 176 thousand shares were bought and sold for approximately $319.25 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.08 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -45.84% during the next 3 months and, with a 90% probability hold a price between $0.588 and $6.10 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

EFTR Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, April 19, 2024, and so far it has risen 6.47%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The eFFECTOR Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.82 and $8.02. A break-up above any of these levels will issue buy signals. eFFECTOR Therapeutics, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for eFFECTOR Therapeutics, Inc. stock

eFFECTOR Therapeutics, Inc. finds support from accumulated volume at $1.78 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.110 between high and low, or 6.25%. For the last week, the stock has had daily average volatility of 10.59%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (EFTR) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect eFFECTOR Therapeutics, Inc. to open at $1.81, and during the day (based on 14 day Average True Range), to move between $0.87 and $2.75, which gives a possible trading interval of +/-$0.94 (+/-52.15%) up or down from last closing price. If eFFECTOR Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 104.30% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.78 (1.66%) than the resistance at $1.93 (6.63%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is eFFECTOR Therapeutics, Inc. stock A Buy?

eFFECTOR Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.038 Sell Candidate Unchanged

Predicted Opening Price for eFFECTOR Therapeutics, Inc. of Friday, April 26, 2024

Fair opening price April 26, 2024 Current price
$1.81 ( 0.184%) $1.81

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for EFTR

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.92 6.26 %
R2 1.88 3.94 %
R1 1.86 2.51 %
Current price: 1.81
Support S1 1.77 -2.14 %
S2 1.75 -3.57 %
S3 1.70 -5.89 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.24 23.48 %
R2 2.13 17.68 %
R1 1.93 6.63 %
Current price 1.81
Support S1 1.78 -1.66%
S2 1.70 -6.08%
S3 0 .

FAQ

What is the symbol for eFFECTOR Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for eFFECTOR Therapeutics, Inc. is EFTR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell eFFECTOR Therapeutics, Inc. Stock?
eFFECTOR Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy eFFECTOR Therapeutics, Inc. Stock?
eFFECTOR Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy eFFECTOR Therapeutics, Inc. Stock.

What's the current price of eFFECTOR Therapeutics, Inc. Stock?
As of the end of day on the Apr 25, 2024, the price of an eFFECTOR Therapeutics, Inc. (EFTR) share was $1.81.

What is the 52-week high and low for eFFECTOR Therapeutics, Inc. Stock?
The 52-week high for eFFECTOR Therapeutics, Inc. Stock is $17.75 and the 52-week low is $0.345.

What is the market capitalization of eFFECTOR Therapeutics, Inc. Stock?
As of the Apr 25, 2024, the market capitalization of eFFECTOR Therapeutics, Inc. is 6.674M.

When is the next earnings date for eFFECTOR Therapeutics, Inc.?
The upcoming earnings date for eFFECTOR Therapeutics, Inc. is May 14, 2024.
Click to get the best stock tips daily for free!

About eFFECTOR Therapeutics, Inc.

eFFECTOR Therapeutics. eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer. The company is also developing Zotatifin, a small molecule designed to inhibit euk... EFTR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT